Instruction for use: Synalar C

Active substance Clioquinol + Fluocinolone acetonide

ATX code D07BC02 Fluorocinolone in combination with antiseptics

Pharmacological group

Glucocorticosteroids in combinations

Nosological classification (ICD-10)

B35-B49 Mycoses

Fungal infections of the skin, Fungal lesions of skin folds, Fungal infection, Fungal skin lesions, Fungal lesions of the bronchial mucosa, Fungal lesions of the oral mucosa, Infections fungal, Infections of skin fungal

B49 Mycosis, unspecified

Common mycoses, Visceral mycosis, Deep endemic mycoses, Keratomycosis, Cutaneous mycosis, Pulmonary mycosis, Mycosis, Mycosis eyes, Mycoses of the gastrointestinal tract, Mycosis of large skin folds, Mycosis with secondary bacterial infection, Mycoses in patients with immunodeficiency, Systemic fungal infections, Tropical mycoses, Fungal infections of the skin, Fungal lesions of skin folds, Fungal infection, Fungal skin lesions, Fungal lesions of the bronchial mucosa, Fungal lesions of the oral mucosa, Infections fungal, Infections of skin fungal, Skin mycoses, Mycosis systemic, Mycosis of the mucous membranes

L00-L08 Infections of the skin and subcutaneous tissue

L08.9 Local infection of skin and subcutaneous tissue, unspecified

Soft tissue abscess, Bacterial or fungal infection of the skin, Bacterial skin infections, Bacterial infections of soft tissues, Bacterial skin infections, Bacterial skin lesions, Viral infection of the skin, Viral skin infections, Inflammation of cellulose, Inflammation of the skin at the injection site, Inflammatory skin diseases, Pustular skin diseases, Purulent-inflammatory disease of skin and soft tissues, Purulent-inflammatory skin diseases, Purulent-inflammatory diseases of the skin and its appendages, Purulent-inflammatory diseases of soft tissues, Purulent skin infections, Purulent infections of soft tissues, Skin Infections, Infections of the skin and skin structures, Infectious lesions of the skin, Infectious diseases of the skin, Skin Infection, Infection of the skin and its appendages, Infection of the skin and subcutaneous structures, Infection of the skin and mucous membranes, Infection of the skin, Dermal bacterial infections, Uncomplicated skin infections, Uncomplicated soft tissue infections, Surface erosion of the skin with secondary infection, Umbilical infection, Mixed skin infections, Specific infectious processes in the skin, Superinfection of the skin, Necrotizing subcutaneous infections

Composition and form of release

1 g of cream contains fluocinolone acetonide 0.25 mg and clioquinol 30 mg.

pharmachologic effect

Pharmacological action - anti-inflammatory, antibacterial, antifungal.

Indication

Inflammatory diseases of the skin in the presence or likelihood of a secondary bacterial infection and / or mycosis.

Contraindications

Primary skin infections caused by bacteria, fungi, viruses, acne, acne, perioral dermatitis, itching of the anus and genitals, diaper rash.

Side effects

Irritation, allergic reactions, high doses and prolonged use can cause oppression of adrenal function (the formation of atrophic bands, thinning and atrophy of the skin, telangiectasia, systemic effects).

Dosing and Administration

A small amount is applied to the skin 2-3 times a day in a thin layer, carefully and carefully rubbed. Occlusal dressings can be used.

Storage conditions

At a temperature not higher than 25 ° C.

Keep out of the reach of children.

Shelf life

3 years.

Do not use after the expiry date printed on the package.